| Literature DB >> 33338116 |
Claudia Marcela Chalela1, Angela Maria Peña1,2, Angela Maria Roa1, David L Reyes1, Jennifer Paola Rueda1, Luis Antonio Salazar1,2, Manuel Rosales2, Edgar David Gomez1,3, Edgar Augusto Bernal4, Claudia Lucia Sossa Melo1,2.
Abstract
Chagas disease (CD) is a protozoan zoonosis caused by Trypanosoma cruzi. Reactivation of CD occurs via drug-induced immunosuppression before and during transplantation. Here, we report the case of a 62-year-old man diagnosed with classic Hodgkin lymphoma who received highly aggressive conditioning chemotherapy before undergoing stem cell transplantation (SCT). The patient tested positive for CD in pre-transplantation evaluation. The patient exhibited persistent fever and elevated C-reactive protein levels before and after SCT, and was treated with antibiotics. Micro-Strout test showed evidence of trypomastigotes and he was treated with benznidazole until tested negative. Post-transplantation seropositive patients should be screened for possible reactivation.Entities:
Year: 2020 PMID: 33338116 DOI: 10.1590/0037-8682-0143-2020
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN: 0037-8682 Impact factor: 1.581